Jonathan Krinsky, BTIG chief market technician, joins 'Closing Bell' to discuss why he's cautious on Apple and the market ...

BTIG says a “considerable amount of our time is spent thinking and talking about” Fannie Mae (FNMA) and Freddie Mac (FMCC) because those ...

The brokerage issued a sell rating on the real estate investment trust’s stock. Separately, BTIG Research assumed coverage on ...

Geode Capital Management LLC grew its holdings in Embecta Corp. (NASDAQ:EMBC – Free Report) by 3.4% during the third quarter, ...

Fintel reports that on December 23, 2024, BTIG downgraded their outlook for Innovative Industrial Properties, Inc. - ...

Lennar (LEN – Research Report) received a Hold rating and price target from BTIG analyst Carl Reichardt yesterday. The company’s shares ...

BTIG said it would be cautious on Apple's ( NASDAQ: AAPL) stock heading into January 2025. Analyst Jonathan Krinsky said the market can continue to make upside progress into the year-end and see a new ...

On Friday, Cerus Corp (CERS) stock saw a decline, ending the day at $1.56 which represents a decrease of $-0.10 or -6.02% from the prior close of $1.66. The stock opened at $1.65 and touched a low of ...

BTIG said it would be cautious on Apple's (NASDAQ:AAPL) stock heading into January 2025. Analyst Jonathan Krinsky said the market can continue to make upside progress into the year-end and see a ...

BioNano Genomics Inc (BNGO) stock saw a decline, ending the day at $0.21 which represents a decrease of $-0.01 or -4.55% from the prior close of $0.22. The stock opened at $0.22 and touched a low of ...

BTIG analyst Julian Harrison initiated coverage of Avalo Therapeutics (AVTX) with a Buy rating and $40 price target The firm sees the company’s AVTX-009 as having best-in-class features that could ...

BTIG raised the firm’s price target on Darden (DRI) to $205 from $195 and keeps a Buy rating on the shares after its Q2 ...